Adanate
PrivateLast Round
Series A
Nov 17, 2021
Total Funding Raised
$30M
Company Overview
Adanate is a biotechnology company that develops antibody therapeutics aimed at boosting innate and adaptive immunity to effectively manage cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adanate Comparables
Compare Adanate with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Immune-Onc Therapeutics | 89% | |
| OncoResponse | 82% | |
| Biond Biologics | 79% | |
Adanate Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 17, 2021 |
Adanate Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Westlake Village BioPartners | Series A |
| Avalon Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 17, 2021
$30M round led by Westlake Village BioPartners.
Adanate Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Adanate's valuation, stock price, and market status.